Jaipur
08042782001
+918209542042

GLISITAPTIN M 1000 is a trusted oral anti-diabetic medicine that combines the benefits of Sitaglipti...

Introduction

GLISITAPTIN M 1000 is a prescription oral antidiabetic medicine specifically designed to manage Type 2 Diabetes Mellitus in adults. It combines two well‑researched active ingredients — Sitagliptin Phosphate (50 mg) and Metformin Hydrochloride 1000—in a single tablet, offering a dual‑action formula that improves blood glucose control economically and effectively.

Diabetes management in India increasingly focuses on combining medications that work in synergy to reduce blood sugar levels while supporting long‑term metabolic health. GLISITAPTIN M 1000 delivers on this by combining the benefits of a DPP‑4 inhibitor and a biguanide agent, making it suitable for patients who have not achieved target glucose levels with diet and exercise alone.

Uses of GLISITAPTIN M 1000

GLISITAPTIN M 1000 is primarily prescribed for the management and control of high blood sugar levels in adults with Type 2 Diabetes Mellitus. Its trusted uses include:

  • Improving glycemic control when diet and exercise alone are insufficient.

  • Adjunct therapy for patients already taking metformin without adequate effect.

  • Reducing both fasting and post‑meal (postprandial) glucose levels.

  • Supporting stable HbA1c (glycated hemoglobin) levels, an important long‑term marker of diabetes control.

  • Can be combined with other oral antidiabetic drugs or insulin when required under medical supervision.

  • Managing blood glucose effectively helps lower the risk of severe diabetes complications such as heart disease, kidney damage, nerve damage (neuropathy), and vision issues.


Benefits of GLISITAPTIN M 1000

GLISITAPTIN M 1000 provides several therapeutic benefits for patients living with type 2 diabetes:

1. Dual Mechanism for Better Sugar Control

  • Sitagliptin inhibits DPP‑4 (Dipeptidyl Peptidase‑4), increasing incretin hormones that boost insulin release and decrease glucagon when blood glucose is high.

  • Metformin reduces glucose production in the liver and improves insulin sensitivity, helping the body use glucose more effectively.

2. Reduced Risk of Hypoglycemia
Because sitagliptin works through a glucose‑dependent mechanism, there is a lower risk of low blood sugar episodes compared to some older diabetes drugs. 

3. Support for Weight Management
Metformin is known to have a neutral or mild weight‑reducing effect, which can be beneficial for many patients managing both diabetes and weight concerns.

4. Convenient Dosing
Combining two agents into a single tablet simplifies the treatment plan, improving medication adherence and overall glycemic control. 

5. Comprehensive Glucose Control
This combination offers robust performance against both fasting and after‑meal glucose spikes, helping maintain consistent blood sugar levels throughout the day.

Dosage of GLISITAPTIN M 1000

The proper dosage of GLISITAPTIN M 1000 should always be determined by a qualified healthcare professional based on the patient’s individual condition, blood glucose levels, and treatment response.

A typical regimen includes:

  • One tablet, twice daily with meals; this helps reduce gastrointestinal discomfort commonly associated with metformin.

  • Swallow the tablet whole with water.

  • Maintain a consistent schedule to maximize glucose control.

  • Do not alter or stop the dosage without consulting your doctor.

Regular monitoring of blood sugar levels and periodic follow‑ups with your physician are essential to assess effectiveness and make any necessary adjustments.

Side Effects of GLISITAPTIN M 1000

GLISITAPTIN M 1000 is generally well tolerated, but patients may experience some side effects, especially when starting treatment or increasing the dose. Common side effects include:

  • Gastrointestinal discomfort such as nausea, diarrhea, or stomach upset

  • Headache

  • Upper respiratory tract infections (e.g., cold, sore throat)

  • Mild dizziness

Rare but Serious Side Effects:
Although uncommon, the following require immediate medical attention:

  • Lactic acidosis—a serious condition linked to metformin, marked by muscle pain, difficulty breathing, stomach pain, or unusual tiredness.

  • Pancreatitis—indicated by persistent severe abdominal pain and nausea.

  • Allergic reactions such as rash or swelling.

If you experience unusual symptoms or severe side effects, stop the medication and consult your healthcare provider.

Precautions and Warnings

Before starting GLISITAPTIN M 1000, consider the following precautions:

1. Kidney and Liver Function:
Patients with kidney or liver impairment need careful evaluation and possible dose adjustment. 

2. Pregnancy and Breastfeeding:
Use only under strict medical supervision, as safety data in these groups is limited. 

3. Alcohol:
Avoid excessive alcohol intake, as it may increase the risk of lactic acidosis and influence blood sugar levels.

4. Drug Interactions:
Inform your doctor about all medications, supplements, and herbal products you are taking to avoid interactions. 

5. Regular Monitoring:
Regular blood glucose testing is vital to ensure effective diabetes management and to help prevent complications.

Conclusion

GLISITAPTIN M 1000 is a clinically effective sitagliptin‑metformin combination formulated for adults with Type 2 Diabetes Mellitus who need better glycemic control beyond diet and exercise alone. Its dual‑action approach provides improved blood sugar regulation, a lower risk of hypoglycemia, and ease of use in a single tablet. When taken as prescribed, with regular medical supervision and lifestyle support (diet and exercise), GLISITAPTIN M 1000 can play a pivotal role in long‑term diabetes management and help reduce the risk of chronic complications. www.sterispharma.com



 2025-09-12T10:43:50

Keywords